| Gandelman Cardiology, Pc | |
|
81 Holly Hill Ln Fl 3 Greenwich CT 06830-2945 | |
| (203) 869-5515 | |
| (203) 869-5765 |
| Full Name | Gandelman Cardiology, Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 81 Holly Hill Ln Fl 3, Greenwich, Connecticut |
| Authorized Official Name and Position | Glenn Gandelman (PRESIDENT) |
| Authorized Official Contact | 2038695515 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Gandelman Cardiology, Pc 81 Holly Hill Ln Fl 3 Greenwich CT 06830-2945 Ph: (203) 869-5515 | Gandelman Cardiology, Pc 81 Holly Hill Ln Fl 3 Greenwich CT 06830-2945 Ph: (203) 869-5515 |
| NPI Number | 1629264353 |
|---|---|
| Provider Enumeration Date | 09/17/2007 |
| Last Update Date | 01/19/2024 |
| Medicare PECOS PAC ID | 1355437484 |
|---|---|
| Medicare Enrollment ID | O20071019000351 |
News Archive
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.
Nearly three-quarters (72%) of people who lost their health insurance when they lost their jobs over the last two years said that they skipped needed health care or did not fill prescriptions because of cost, according to a new Commonwealth Fund report. The same proportion is also struggling with medical bills or medical debt, compared to about half (49%) who lost jobs but not their health insurance.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629264353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | (* (Not Available)) | Primary |
| Provider Name | Glenn Gandelman |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1033117437 PECOS PAC ID: 5294781100 Enrollment ID: I20060307000073 |
News Archive
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.
Nearly three-quarters (72%) of people who lost their health insurance when they lost their jobs over the last two years said that they skipped needed health care or did not fill prescriptions because of cost, according to a new Commonwealth Fund report. The same proportion is also struggling with medical bills or medical debt, compared to about half (49%) who lost jobs but not their health insurance.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 7 days ago
| Provider Name | Marcus A Mayus |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1073734935 PECOS PAC ID: 0345315180 Enrollment ID: I20080813000806 |
News Archive
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.
Nearly three-quarters (72%) of people who lost their health insurance when they lost their jobs over the last two years said that they skipped needed health care or did not fill prescriptions because of cost, according to a new Commonwealth Fund report. The same proportion is also struggling with medical bills or medical debt, compared to about half (49%) who lost jobs but not their health insurance.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 7 days ago
| Provider Name | Yvette D Bailey |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1528170198 PECOS PAC ID: 9931186632 Enrollment ID: I20120910000512 |
News Archive
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.
Nearly three-quarters (72%) of people who lost their health insurance when they lost their jobs over the last two years said that they skipped needed health care or did not fill prescriptions because of cost, according to a new Commonwealth Fund report. The same proportion is also struggling with medical bills or medical debt, compared to about half (49%) who lost jobs but not their health insurance.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 7 days ago
| Provider Name | Mohammed Chaudary |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1164770400 PECOS PAC ID: 9537438825 Enrollment ID: I20220224000788 |
News Archive
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.
Nearly three-quarters (72%) of people who lost their health insurance when they lost their jobs over the last two years said that they skipped needed health care or did not fill prescriptions because of cost, according to a new Commonwealth Fund report. The same proportion is also struggling with medical bills or medical debt, compared to about half (49%) who lost jobs but not their health insurance.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 7 days ago
News Archive
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.
Nearly three-quarters (72%) of people who lost their health insurance when they lost their jobs over the last two years said that they skipped needed health care or did not fill prescriptions because of cost, according to a new Commonwealth Fund report. The same proportion is also struggling with medical bills or medical debt, compared to about half (49%) who lost jobs but not their health insurance.
Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.
› Verified 7 days ago
Center For Gastrointestinal Medicine Of Fairfield & Westchester, P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 500 W Putnam Ave, Suite 100, Greenwich, CT 06830 Phone: 203-863-2900 Fax: 203-863-2901 | |
Signature Concierge Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 32 Field Point Rd, Greenwich, CT 06830 Phone: 203-962-1009 | |
Quality Health Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 12 Havemeyer Pl, Greenwich, CT 06830 Phone: 860-554-9021 | |
Christopher M Edelmann,m.d.,p.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 42 Sherwood Pl, Greenwich, CT 06830 Phone: 203-869-0502 Fax: 203-869-1852 | |
Family Centers Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1 Wilbur Peck Ct Lowr Level, Greenwich, CT 06830 Phone: 203-829-2822 Fax: 203-829-2940 | |
Halsamd Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 115 E Putnam Ave, Greenwich, CT 06830 Phone: 203-517-4600 Fax: 888-397-2148 | |
Palliative Care Pans Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4 Charter Oak Ln, Greenwich, CT 06830 Phone: 203-921-7836 Fax: 203-433-5823 |